Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection
出版年份 2013 全文链接
标题
Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection
作者
关键词
-
出版物
BLOOD
Volume 123, Issue 1, Pages 61-69
出版商
American Society of Hematology
发表日期
2013-10-26
DOI
10.1182/blood-2013-08-521229
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation
- (2013) T. J. Henrich et al. JOURNAL OF INFECTIOUS DISEASES
- Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases
- (2013) Lijing Li et al. MOLECULAR THERAPY
- Combined approaches for HIV cure
- (2013) David M. Margolis et al. Current Opinion in HIV and AIDS
- Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease
- (2012) Hans-Peter Kiem et al. Cell Stem Cell
- Creating genetic resistance to HIV
- (2012) John C Burnett et al. CURRENT OPINION IN IMMUNOLOGY
- Zinc-finger Nuclease Editing of Human cxcr4 Promotes HIV-1 CD4+ T Cell Resistance and Enrichment
- (2012) Jinyun Yuan et al. MOLECULAR THERAPY
- FLASH assembly of TALENs for high-throughput genome editing
- (2012) Deepak Reyon et al. NATURE BIOTECHNOLOGY
- Developing strategies for HIV-1 eradication
- (2012) Christine M. Durand et al. TRENDS IN IMMUNOLOGY
- Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7
- (2012) Nicholas F. Parrish et al. PLoS Pathogens
- Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years
- (2011) G. Hütter et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases
- (2011) Craig B. Wilen et al. PLoS Pathogens
- HIV Infection, Inflammation, Immunosenescence, and Aging
- (2010) Steven G. Deeks Annual Review of Medicine
- Evidence for the cure of HIV infection by CCR5 32/ 32 stem cell transplantation
- (2010) K. Allers et al. BLOOD
- Nonprogressive and Progressive Primate Immunodeficiency Lentivirus Infections
- (2010) Jason M. Brenchley et al. IMMUNITY
- HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4+ T Cells
- (2010) J. M. Pfaff et al. JOURNAL OF VIROLOGY
- Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
- (2010) Nathalia Holt et al. NATURE BIOTECHNOLOGY
- Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures
- (2010) Yannick Doyon et al. NATURE METHODS
- Genome editing with engineered zinc finger nucleases
- (2010) Fyodor D. Urnov et al. NATURE REVIEWS GENETICS
- CXC chemokine receptor 4 expressed in T cells plays an important role in the development of collagen-induced arthritis
- (2010) Soo-Hyun Chung et al. ARTHRITIS RESEARCH & THERAPY
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- The utilization of humanized mouse models for the study of human retroviral infections
- (2009) Rachel Van Duyne et al. Retrovirology
- A pièce de resistance: how HIV-1 escapes small molecule CCR5 inhibitors
- (2009) John P Moore et al. Current Opinion in HIV and AIDS
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
- (2008) Elena E Perez et al. NATURE BIOTECHNOLOGY
- Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection
- (2008) Gerd Fätkenheuer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
- (2008) B. F. Keele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started